These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11403061)

  • 1. Riluzole for motor neurone disease. Large, more economical trial is needed.
    Wheatley K; Gray R
    BMJ; 2001 May; 322(7297):1305. PubMed ID: 11403061
    [No Abstract]   [Full Text] [Related]  

  • 2. Riluzole for motor neurone disease. More trials are needed.
    Sandercock J; Burls A; Hyde C; Fry-Smith A; Barton P; Bryan S; Stewart A
    BMJ; 2001 May; 322(7297):1305. PubMed ID: 11403060
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review.
    Stewart A; Sandercock J; Bryan S; Hyde C; Barton PM; Fry-Smith A; Burls A
    Health Technol Assess; 2001; 5(2):1-97. PubMed ID: 11809124
    [No Abstract]   [Full Text] [Related]  

  • 4. Rilutek now subsidised.
    Smith W
    Nurs N Z; 2013 Nov; 19(10):4. PubMed ID: 24427977
    [No Abstract]   [Full Text] [Related]  

  • 5. Riluzole for motor neurone disease. Reply from chairman of appraisal committee at NICE.
    Barnett D
    BMJ; 2001 Sep; 323(7312):573. PubMed ID: 11573490
    [No Abstract]   [Full Text] [Related]  

  • 6. Riluzole: a glimmer of hope in the treatment of motor neurone disease.
    Kiernan MC
    Med J Aust; 2005 Apr; 182(7):319-20. PubMed ID: 15804220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Easier access to motor neurone drug.
    Smith W
    Nurs N Z; 2004 Oct; 10(9):5. PubMed ID: 19777649
    [No Abstract]   [Full Text] [Related]  

  • 8. Riluzole: a glimmer of hope in the treatment of motor neurone disease.
    Henderson RD; McCombe PA
    Med J Aust; 2005 Aug; 183(3):164; author reply 164-5. PubMed ID: 16053424
    [No Abstract]   [Full Text] [Related]  

  • 9. Rilutek should be subsidised.
    Smith W
    Nurs N Z; 2005 Oct; 11(9):4. PubMed ID: 16529266
    [No Abstract]   [Full Text] [Related]  

  • 10. Access to palliative care for people with motor neurone disease in New Zealand: a patient's perspective.
    Williams B
    N Z Med J; 2005 Oct; 118(1224):U1711. PubMed ID: 16258583
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of motor neurone disease.
    Turner M
    Practitioner; 2001 Jun; 245(1623):530-2, 536-8. PubMed ID: 11436263
    [No Abstract]   [Full Text] [Related]  

  • 12. Preface: the state of the science of all motor neuron diseases.
    Weiss MD; Carter GT
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):xix-xx. PubMed ID: 18625405
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of riluzole: who are the patients enrolled in the studies?
    Logroscino G; Zoccolella S
    Amyotroph Lateral Scler; 2007 Apr; 8(2):124-5; author reply 125. PubMed ID: 17453643
    [No Abstract]   [Full Text] [Related]  

  • 14. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002).
    Zoing MC; Burke D; Pamphlett R; Kiernan MC
    J Clin Neurosci; 2006 Jan; 13(1):78-83. PubMed ID: 16410201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audit of outcomes in motor neuron disease (MND) patients treated with riluzole.
    Mitchell JD; O'brien MR; Joshi M
    Amyotroph Lateral Scler; 2006 Jun; 7(2):67-71. PubMed ID: 16753969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic Studies in Motor Neurone Disease: A Systematic Methodological Review.
    Moore A; Young CA; Hughes DA
    Pharmacoeconomics; 2017 Apr; 35(4):397-413. PubMed ID: 27975196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slowing down ALS--is this good or bad?
    Munsat TL
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S19-22. PubMed ID: 11465919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riluzole.
    Reynolds DJ
    Lancet; 1996 Dec; 348(9042):1661. PubMed ID: 8962008
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness associated with amyotrophic lateral sclerosis: some questions and answers pending.
    Fiorentino G; Esquinas AM
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):315-316. PubMed ID: 29191046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.